VANGUARD GROUP INC - VALLON PHARMACEUTICALS INC ownership

VALLON PHARMACEUTICALS INC's ticker is VLON and the CUSIP is 92023M101. A total of 14 filers reported holding VALLON PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of VALLON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$6,000
-60.0%
22,146
-5.6%
0.00%
Q2 2022$15,000
-92.1%
23,464
-76.9%
0.00%
Q1 2022$191,000
-80.6%
101,664
-38.4%
0.00%
Q4 2021$986,000164,9230.00%
Other shareholders
VALLON PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Ikarian Capital, LLC 198,085$1,184,0000.18%
Laidlaw Wealth Management LLC 20,200$121,0000.02%
ZEKE CAPITAL ADVISORS, LLC 15,000$90,0000.01%
BOOTHBAY FUND MANAGEMENT, LLC 21,250$127,0000.00%
OSAIC HOLDINGS, INC. 5,533$33,0000.00%
WELLS FARGO & COMPANY/MN 14$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 17,841$106,0000.00%
STATE STREET CORP 11,200$67,0000.00%
MORGAN STANLEY 2,628$16,0000.00%
View complete list of VALLON PHARMACEUTICALS INC shareholders